Dow Down 0.28% Nasdaq Down 0.45%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
0.84 Down 0.01(1.45%) 10:46AM EDT - Nasdaq Real Time Price
Prev Close:0.85
Open:0.84
Bid:0.82 x 300
Ask:0.84 x 100
1y Target Est:3.50
Beta:1.07
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:0.82 - 0.88
52wk Range:0.65 - 4.00
Volume:86,361
Avg Vol (3m):385,528
Market Cap:50.82M
P/E (ttm):N/A
EPS (ttm):-0.16
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMUC

Comparison

Symbol% ChgMkt Cap
IMUCDown 1.45%50.82M
AGENUp 0.26%186.65M
DNDNDown 1.47%206.74M
STMLDown 1.23%156.13M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback